Copithorne, Caroline

Caroline Copithorne joined the Morgan Stanley Equity Research healthcare team in March 2000 as a Biotechnology Analyst and is a Principal at the firm. Prior to joining the Firm she was a Senior Biotechnology Analyst at Prudential Securities since 1997, and was made Managing Director in 2000. In 2000 she was ranked #1 by biotech companies and #2 by fund managers in Reuters Survey of small and mid-cap companies. In 1999 she was voted "Up and Coming" analyst in the Biotechnology Sector by Institutional Investor and Wall Street Journal "All Star Analyst" for earnings estimate accuracy. Before covering the Biotechnology industry, Caroline was employed in Equity Research at Prudential Securities tracking Capital Goods stocks from 1993-1996. From 1990-1993 she was an Associate in Corporate Finance at Bank of America. Caroline Copithorne graduated from the University of California, Berkeley with a BA in Economics and Microbiology in 1988, and with an MBA/MS in Finance from Carnegie Mellon University in 1990.

Previous Forums
Date/Time		Forum
Jul 27 2001		San Francisco Biotechnology Stocks Forum